Fierce Biotech1 小时
Servier pays $70M to polish Black Diamond's deprioritized solid tumor prospect
Black Diamond Therapeutics has found a partner for its deprioritized solid tumor candidate. Five months after cutting support ...
The Manila Times1 小时
Servier and Black Diamond Therapeutics Announce Global Licensing Agreement for BDTX-4933, A ...
The partnership underscores Servier's commitment to developing targeted therapies that address unmet medical needs in oncology; Servier will develop and commercialize BDTX-4933, a ...